|
|
|
|
| LEADER |
03536nmm a2200385 u 4500 |
| 001 |
EB002121532 |
| 003 |
EBX01000000000000001259589 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
221107 ||| eng |
| 020 |
|
|
|a 9789811939792
|
| 100 |
1 |
|
|a Suar, Mrutyunjay
|e [editor]
|
| 245 |
0 |
0 |
|a Microbial Engineering for Therapeutics
|h Elektronische Ressource
|c edited by Mrutyunjay Suar, Namrata Misra, Chandravanu Dash
|
| 250 |
|
|
|a 1st ed. 2022
|
| 260 |
|
|
|a Singapore
|b Springer Nature Singapore
|c 2022, 2022
|
| 300 |
|
|
|a XI, 374 p. 45 illus., 44 illus. in color
|b online resource
|
| 505 |
0 |
|
|a Part 1 Introduction to Microbial Engineering -- 1 Exploring the Potential of Microbial Engineering: The Prospect, Promise and Essence -- Part 2 Microbial Engineering Approaches -- 2 Role of System Biology in Microbial System -- 3 Synthetic Biology: Refining Human Health -- 4 Probiotic Engineering: A focus on Inflammatory Bowel Disease -- 5 Engineering microbes for smart diagnostics & Lab on Chip -- 6 Bacteriophage and Virus Engineering -- 7 CRISPR Technologies: A tool for Engineering Microbes -- Part 3 Health Benefits -- 8 Recombinant Vaccines: The Revolution Ahead -- 9 Microbe-Host Metabolic Interaction- Probiotic Approach -- 10 Designer Microbes: Oncotherapy approach -- 11 The human gut microbiome in health, disease and therapeutics -- 12 Use of Engineered Bacteria for Production of Green Chemicals & Pharmaceuticals -- 13 Fat Fighting Microbes. Part 4 Innovation & Translation -- 14 Scale-up of engineering strain for industrial applications -- 15 Affordable therapeutics through Engineered Microbes -- 16 COVID-19: Lesson Learnt from Diagnostics to therapeutics.
|
| 653 |
|
|
|a Bioinformatics
|
| 653 |
|
|
|a Computational and Systems Biology
|
| 653 |
|
|
|a Biomedical engineering
|
| 653 |
|
|
|a Medicine / Research
|
| 653 |
|
|
|a Biology / Research
|
| 653 |
|
|
|a Biomedical Engineering and Bioengineering
|
| 653 |
|
|
|a Industrial Microbiology
|
| 653 |
|
|
|a Synthetic Biology
|
| 653 |
|
|
|a Biomedical Research
|
| 653 |
|
|
|a Industrial microbiology
|
| 700 |
1 |
|
|a Misra, Namrata
|e [editor]
|
| 700 |
1 |
|
|a Dash, Chandravanu
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 028 |
5 |
0 |
|a 10.1007/978-981-19-3979-2
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-981-19-3979-2?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 610.72
|
| 520 |
|
|
|a This book highlights the recent advances in the field of microbial engineering and its application in human healthcare. It underscores the systemic and synthetic biology approaches for engineering microbes and discusses novel treatments for inflammatory bowel diseases based on engineered probiotics. The book also reviews the different options and methods for engineering microbes, ranging from recombinant DNA technology to designing microbes for targeting specific sites and delivering therapeutics. Further, it discusses genetically engineered microorganisms for smart diagnostics and describes current approaches in microbial gene editing using CRISPR-Cas9-based tools. Lastly, it summarizes the potential applications of human microbiome engineering in improving human health and explores potential strategies for scaling-up the production of engineered microbial strains for commercial purposes, as well as the challenges. Given its scope, this book is a valuable resource for students,researchers, academics and entrepreneurs interested in understanding microbial engineering for the production of commercial products
|